Services
Parkinson's Disease
Comprehensive management of motor and non-motor Parkinson's symptoms through neurorestoration and basal-ganglia circuit modulation.
Neurorestorative Approach
How We Approach This Condition
Parkinson’s disease is a progressive neurodegenerative condition primarily affecting the dopaminergic system in the basal ganglia. Reduced dopamine production disrupts motor and non-motor circuits in the brain, producing a diverse clinical picture. Resting tremor, muscle rigidity, bradykinesia (slowed movement), and postural instability are the classic motor signs. Yet Parkinson’s is far more than a movement disorder — cognitive difficulties, depression, anxiety, sleep disturbances, and autonomic dysfunction often impose an equal or greater burden on patient quality of life.
Early diagnosis and comprehensive management are key to maintaining functional independence for as long as possible. The neurorestoration approach is not intended to replace proven pharmacological therapy but to work synergistically with it.
Neurorestorative Approach to Parkinson’s
QEEG assessment in Parkinson’s patients frequently reveals characteristic patterns — slowing of brain-wave activity in frontal and parietal regions, and abnormal synchronisation patterns linked to motor symptoms. This activity map forms the starting point for designing targeted interventions.
Transcranial electrical stimulation (TES) is applied to modulate motor and prefrontal cortex excitability, supporting voluntary motor control and executive function. Neurofeedback trains patients to increase specific brain-wave frequencies associated with alertness and cognitive control. Photobiomodulation provides metabolic support for neural tissue vulnerable to oxidative stress in neurodegenerative conditions.
Regular monitoring ensures the protocol continues to be adjusted to the evolving condition, since Parkinson’s is a dynamic disease. Active participation of the patient and family in the care process — including understanding the signs of progress and decline — is an important component of an effective programme.
Modalities Used
Modality selection is tailored to each patient's individual clinical profile.
Treatment Pathway
Steps in Your Care
-
Consultation & History
In-depth clinical interview to understand the patient's history, chief complaint, and recovery goals.
-
Data-Driven Assessment
QEEG examination and objective neurological evaluation to map current nerve-function status.
-
Individual Treatment Plan
A neurorestoration protocol designed specifically from assessment results and the patient's clinical profile.
-
Monitoring & Adjustment
Regular progress evaluation with protocol refinement to achieve optimal recovery outcomes.
Common Questions
Frequently Asked Questions
- Can neurorestoration stop Parkinson's progression?
- Neurorestoration does not claim to halt disease progression, but aims to optimise remaining neural function, slow functional decline, and improve overall quality of life.
- Can this programme be combined with Parkinson's medications?
- Yes. The neurorestoration approach is designed to work alongside existing pharmacological therapy. Any changes to your medication regimen must always be discussed with the prescribing physician.
- Which symptoms are most responsive to neurorestoration?
- Non-motor symptoms such as cognitive difficulties, fatigue, sleep disturbances, and mood fluctuations often show good response. Motor symptoms may improve in some patients, particularly mild to moderate tremor.
- How frequently are treatment sessions required?
- Session frequency is determined after initial assessment and typically ranges from two to three times per week during the initial intensive phase, then reduces to maintenance sessions.
Discuss Your Condition
Contact us to schedule a consultation and initial assessment.